임상 실험실 자동화 시장 : 제품별, 최종 사용자별, 지역별 - 세계 예측(-2030년)

The global clinical lab automation market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the rising global geriatric population, increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. Furthermore, increasing demand for automated instruments due to technological advancements, efficiency, and accuracy; technological advancements in molecular diagnostics; and emerging economies provide significant growth opportunities for this market.

However, the high costs of advanced clinical lab automation equipment and funding and infrastructure limitations in developing countries may restrain the growth of this market. Additionally, equipment maintenance and repair costs and concerns over the security and privacy of patient data pose a major challenge for the players operating in this market.

Among products, in 2023, the systems segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to the increased focus on drug development, and the advantages of automated liquid handling systems to increase efficiency and productivity while reducing errors.

Among end users, in 2023, the hospital laboratories segment is expected to account for the largest share of the clinical lab automation market. The large market share of this segment is attributed to factors such as rising healthcare expenditures, continuous improvements in healthcare infrastructure, and the utilization of advanced techniques and technologies.

An in-depth analysis of the geographical scenario of the global clinical lab automation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the global clinical lab automation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global clinical lab automation market.

The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).

Scope of the Report:

Clinical Lab Automation Market Assessment-by Product

• Systems
  • Automated Liquid Handling Systems
  • Automated ELISA Systems
  • Automated Nucleic Acid Purification Systems
  • Automated Microplate Readers
  • Other Systems
• Clinical Lab Automation Software

Note: Other systems include automated incubators, automated cell counters, and cell imaging systems.

Clinical Lab Automation Market Assessment-by End User

• Hospital Laboratories
• Diagnostic Laboratories
• Other End Users

Note: Other end users include blood banks, forensic labs, and clinical research organizations

Clinical Lab Automation Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency & Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection and Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Factors Affecting Market Growth
  • 4.2.1. Impact Analysis of Market Dynamics
  • 4.2.2. Factor Analysis
• 4.3. Regulatory Analysis
  • 4.3.1. Overview
  • 4.3.2. North America
    • 4.3.2.1. U.S.
    • 4.3.2.2. Canada
  • 4.3.3. Europe
  • 4.3.4. Asia-Pacific
    • 4.3.4.1. China
    • 4.3.4.2. Japan
    • 4.3.4.3. India
  • 4.3.5. Latin America
  • 4.3.6. Middle East
• 4.4. Pricing Analysis
• 4.5. Industry Trends
  • 4.5.1. Shortage of Skilled Professionals Leading to the Increased Use of Automated Systems
  • 4.5.2. Increasing Applications of Next-Generation Sequencing Technology
• 4.6. Porter's Five Forces Analysis
  • 4.6.1. Bargaining Power of Buyers
  • 4.6.2. Bargaining Power of Suppliers
  • 4.6.3. Threat of Substitutes
  • 4.6.4. Threat of New Entrants
  • 4.6.5. Degree of Competition

5. Clinical Lab Automation Market Assessment-by Product

• 5.1. Overview
• 5.2. Systems
  • 5.2.1. Automated Liquid Handling Systems
  • 5.2.2. Automated ELISA Systems
  • 5.2.3. Automated Nucleic Acid Purification Systems
  • 5.2.4. Automated Microplate Readers
  • 5.2.5. Other Systems
• 5.3. Clinical Lab Automation Software

6. Clinical Lab Automation Market Assessment-by End User

• 6.1. Overview
• 6.2. Hospital Laboratories
• 6.3. Diagnostic Laboratories
• 6.4. Other End Users

7. Clinical Lab Automation Market Assessment-by Geography

• 7.1. Overview
• 7.2. North America
  • 7.2.1. U.S.
  • 7.2.2. Canada
• 7.3. Europe
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Rest of Europe
• 7.4. Asia-Pacific
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. India
  • 7.4.4. Rest of Asia-Pacific
• 7.5. Latin America
• 7.6. Middle East & Africa

8. Competition Analysis

• 8.1. Overview
• 8.2. Key Growth Strategies
• 8.3. Competitive Benchmarking
• 8.4. Competitive Dashboard
  • 8.4.1. Industry Leaders
  • 8.4.2. Market Differentiators
  • 8.4.3. Vanguards
  • 8.4.4. Emerging Companies
• 8.5. Market Share Analysis (2022)
  • 8.5.1. Danaher Corporation (U.S.)
  • 8.5.2. Hamilton Company (U.S.)
  • 8.5.3. Abbott Laboratories (U.S.)

9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

• 9.1. Danaher Corporation
• 9.2. Hamilton Company
• 9.3. Abbott Laboratories
• 9.4. F. Hoffmann-La Roche AG
• 9.5. Thermo Fisher Scientific, Inc.
• 9.6. Bio-Rad Laboratories, Inc.
• 9.7. Revvity, Inc. (Formerly Known as PerkinElmer, Inc.)
• 9.8. Agilent Technologies, Inc.
• 9.9. Waters Corporation
• 9.10. Tecan Group Ltd.
• 9.11. Siemens Healthineers Ag
• 9.12. Becton, Dickinson, and Company
• 9.13. Hudson Robotics, Inc.

(Note: SWOT Analysis of Top 5 Companies is Provided)

10. Appendix

• 10.1. Available Customization
• 10.2. Related Reports